Jasmin Quandt

6PUBLICATIONS
38CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical virologyNanomedicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 22, 2026
Safety and Immunogenicity of BNT162b2 in Antiretroviral Therapy-Treated People With HIV.

|Jul 16, 2025
Author Correction: BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.

Uğur Şahin, Alexander Muik, Isabel Vogler

|Jun 02, 2022
Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes.

Jasmin Quandt, Alexander Muik, Nadine Salisch

|May 27, 2021
BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.

Ugur Sahin, Alexander Muik, Isabel Vogler

|Jan 20, 2021
Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.

Ugur Sahin, Alexander Muik, Evelyna Derhovanessian

|Sep 30, 2020
COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses.

Ugur Sahin, Alexander Muik, Evelyna Derhovanessian

Pageof 1

Frequent Collaborators

6 joint publications

Isabel Vogler

5 joint publications

Ugur Sahin

5 joint publications

Alexander Muik

4 joint publications

Mathias Vormehr